What does Pramipexole hydrochloride (Senflor) do? A number of patients and family members with Parkinson’s disease have asked this question. And there are many patients and family members from various sources have learned that Parkinson’s disease is due to degeneration of the nigrostriatal area of the midbrain, resulting in a decrease in the production of dopamine neurotransmitter, which cannot maintain the normal needs of the body, while the production of another acetylcholine is normal, and this imbalance, which makes a person appear a series of Parkinson’s disease symptoms. In terms of medication, Medopa and Xanax belong to compound levodopa preparations, which enter the body to directly replenish the brain’s missing dopamine neurotransmitters. Kodan is taken together with Medopa to promote more transit absorption of Medopa in the body, while Antan works as an anticholinergic drug to inhibit the hyperactivity of acetylcholine and improve the symptoms of Parkinson’s disease. Pramipexole hydrochloride is taken by many patients who do not know what role it plays? Pramipexole hydrochloride is a non-ergot dopamine agonist that activates dopamine receptors by binding directly to dopamine receptors in dopamine nerve cells in the brain, thereby acting as a therapeutic agent to improve the symptoms of Parkinson’s disease. Pramipexole hydrochloride is highly selective for dopamine receptor binding, improving motor symptoms such as tremor by agonizing D2 receptors and relieving non-motor symptoms such as depression by agonizing D3 receptors. The long duration of action of pramipexole hydrochloride provides a more stable and sustained stimulation of dopaminergic receptors, and therefore is not as prone to motor complications as dopamine analogs, facilitating the long-term control of patients’ symptoms. Pramipexole hydrochloride is currently available in three types, 0.25mg, 1mg, and 0.75mg (Pramipexole Hydrochloride Extended Release Tablets), and the specific dose to be taken will need to be guided by a Parkinson’s disease clinic specialist according to each patient’s condition. Pramipexole hydrochloride has therapeutic effects as well as adverse effects. A small number of patients experience adverse effects such as nausea, dyskinesia, hypotension, dizziness, drowsiness, insomnia, constipation, hallucinations, headache and fatigue; however, the vast majority are mild to moderate, usually occurring early in the course of treatment, and disappearing in most patients as treatment continues. Patients taking Pramipexole Hydrochloride for long periods of time should be aware that the drug relies on the kidneys for clearance in the body and that kidney function should be checked regularly. If renal insufficiency is present, the use of the drug should be reduced, and a Parkinson’s disease specialist should be consulted for specific dosage.